Immunoassay News and Research

RSS
Mayo clinic researchers develop a potential test for Machado-Joseph disease

Mayo clinic researchers develop a potential test for Machado-Joseph disease

Porvair Sciences offers optimized microplates for affinity binding assays

Porvair Sciences offers optimized microplates for affinity binding assays

Rapid SARS‐CoV‐2 IgM‐IgG combined antibody test

Rapid SARS‐CoV‐2 IgM‐IgG combined antibody test

Temporal predictors of SARS-CoV-2 antibodies

Temporal predictors of SARS-CoV-2 antibodies

The Native Antigen Company introduces ten new SARS-CoV-2 specific antibodies

The Native Antigen Company introduces ten new SARS-CoV-2 specific antibodies

Antigen testing detects SARS-CoV-2 better than PCR

Antigen testing detects SARS-CoV-2 better than PCR

Plasma ACE2 concentration associated with increased risk of major cardiovascular events

Plasma ACE2 concentration associated with increased risk of major cardiovascular events

Production of six monoclonal antibodies against SARS-CoV-2 spike protein

Production of six monoclonal antibodies against SARS-CoV-2 spike protein

AbC-19 blood test detects COVID-19 antibodies 20 weeks after first symptoms/PCR positive result

AbC-19 blood test detects COVID-19 antibodies 20 weeks after first symptoms/PCR positive result

Discovery of high affinity binders for SARS-CoV-2 spike protein

Discovery of high affinity binders for SARS-CoV-2 spike protein

Siemens’ SARS-CoV-2 antibody immunoassays meet regulatory targets

Siemens’ SARS-CoV-2 antibody immunoassays meet regulatory targets

COVAM assay may help select convalescent plasma units for treatment of  acute COVID-19

COVAM assay may help select convalescent plasma units for treatment of acute COVID-19

SARS-CoV-2 infects monocytes and macrophages, without cytopathic effect

SARS-CoV-2 infects monocytes and macrophages, without cytopathic effect

3D printed nanoparticle biosensing platform detects SARS-CoV-2 antibodies within seconds

3D printed nanoparticle biosensing platform detects SARS-CoV-2 antibodies within seconds

Toyonaka Municipal Hospital reports successful control of COVID-19

Toyonaka Municipal Hospital reports successful control of COVID-19

New Gyrolab AAVX Titer Kit launched to support the development cell and gene therapies

New Gyrolab AAVX Titer Kit launched to support the development cell and gene therapies

NIH provides scale-up and manufacturing support for new COVID-19 testing technologies

NIH provides scale-up and manufacturing support for new COVID-19 testing technologies

Brazilian state of Maranhão heading towards SARS-CoV-2 herd immunity, say researchers

Brazilian state of Maranhão heading towards SARS-CoV-2 herd immunity, say researchers

Promega introduces new serological antibody test for COVID-19

Promega introduces new serological antibody test for COVID-19

Fujirebio announces launch of clinical testing for new SARS-CoV-2 Antigen assay

Fujirebio announces launch of clinical testing for new SARS-CoV-2 Antigen assay